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http://www.biomedcentral.com/1471-2105/14/353RESEARCH ARTICLE Open AccessThe causal effect of red blood cell folate on
genome-wide methylation in cord blood: a
Mendelian randomization approach
Alexandra M Binder1* and Karin B Michels1,2Abstract
Background: Investigation of the biological mechanism by which folate acts to affect fetal development can
inform appraisal of expected benefits and risk management. This research is ethically imperative given the ubiquity
of folic acid fortified products in the US. Considering that folate is an essential component in the one-carbon
metabolism pathway that provides methyl groups for DNA methylation, epigenetic modifications provide a putative
molecular mechanism mediating the effect of folic acid supplementation on neonatal and pediatric outcomes.
Results: In this study we use a Mendelian Randomization Unnecessary approach to assess the effect of red blood
cell (RBC) folate on genome-wide DNA methylation in cord blood. Site-specific CpG methylation within the
proximal promoter regions of approximately 14,500 genes was analyzed using the Illumina Infinium Human
Methylation27 Bead Chip for 50 infants from the Epigenetic Birth Cohort at Brigham and Women’s Hospital in
Boston. Using methylenetetrahydrofolate reductase genotype as the instrument, the Mendelian Randomization
approach identified 7 CpG loci with a significant (mostly positive) association between RBC folate and methylation
level. Among the genes in closest proximity to this significant subset of CpG loci, several enriched biologic
processes were involved in nucleic acid transport and metabolic processing. Compared to the standard ordinary
least squares regression method, our estimates were demonstrated to be more robust to unmeasured confounding.
Conclusions: To the authors’ knowledge, this is the largest genome-wide analysis of the effects of folate on
methylation pattern, and the first to employ Mendelian Randomization to assess the effects of an exposure on
epigenetic modifications. These results can help guide future analyses of the causal effects of periconceptional
folate levels on candidate pathways.
Keywords: Mendelian randomization, DNA methylation, Folate, Epigenomic epidemiologyBackground
Identification of the protective effect of periconceptional
folic acid supplementation against neural tube defects in
neonates led to the mandated fortification of flours and
other grain products in several countries [1-4]. In addition
to the prevention of neural tube defects, folic acid supple-
mentation has been associated with decreased risk of
other congenital malformations, such as heart defects and
oral clefts [5-8]. Despite these benefits, concern has been
raised to possible adverse effects. In mouse models, mater-
nal methyl donor supplementation was associated with* Correspondence: abinder@hsph.harvard.edu
1Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
Full list of author information is available at the end of the article
© 2013 Binder and Michels; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumincreased risk of allergic airway disease [9,10]. However,
subsequent human studies of possible detrimental effects
have been relatively inconclusive [11-14]. An understand-
ing of the biological mechanism by which folate acts to
affect fetal development can inform appraisal of expected
benefits and risk management, and is ethically imperative
due to the ubiquity of fortified foods. Folate, an essential
vitamin that can be obtained from diet and synthetic
supplements, is an important component in the one-
carbon metabolism that frees up methyl goups for DNA
methylation. Thus, epigenetic modifications provide a pu-
tative molecular mechanism mediating the effect of folic
acid supplementation on neonatal and pediatric outcomes.
Prior observational studies have reported inconsistent
associations between maternal folic acid supplementationentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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specifically among imprinted genes [15-17]. One difficulty
when studying the association between folic acid sup-
plementation and DNA methylation is the possibility of
effects being obfuscated by the influence of diet on total
maternal folate levels contributing to dose misclassification.
Analyses of the effects of folate levels may also be biased
due to the unmeasured confounding by multifaceted envir-
onmental exposures associated with socio-economic status
that may also influence epigenomic profile. Therefore new
approaches are necessary to consistently estimate the causal
effect of folate on DNA methylation.
Standard methods to control for confounding in
observational studies include matching, restriction, strati-
fication, regression analyses, inverse probability weighting,
and g-estimation. However, these techniques are limited
by their capacity to only adjust for observed confounders,
and rely on the unverifiable condition of no unmeasured
confounding to estimate causal effects. Instrumental vari-
able analysis, a conventional method in econometrics that
has more recently been applied to public health research,
provides a means to adjust for all confounders without
exposure randomization. The application of instrumental
variable analysis has been reviewed elsewhere [18-20].
Generally, instrumental variable analysis requires a vari-
able (instrument) that has a causal effect on the exposure
and only affects the outcome of interest through the
exposure, and for which there is no common cause of the
instrument and outcome (Figure 1). In addition to these
three assumptions, to identify the causal effect we must
make a fourth assumption concerning the nature of the
influence of the exposure on the outcome [20]. Either we
must posit a constant treatment effect, which is implicitlyA Y
C
U
Z
Figure 1 The structure of an observation study to assess the
association between exposure (A) and outcome (Y) in the
presence of both measured (C) and unmeasured confounding
(U); Z represents a possible instrument for an instrumental
variable analysis. In this study, A represents log transformed RBC
folate, the outcome Y is site-specific methylation, C is intention to
conceive, our surrogate for confounding by periconceptional behaviors,
and our instrument Z is MTHFR genotype modeled additively.assumed by the two-stage least squares method outlined
below, or no effect modification by the instrument on the
exposure-outcome association [20]. The two-stage least
squares (2SLS) method for instrumental variable estima-
tion for a continuous outcome takes the form:
A ¼ αZ þ εa ð1Þ
Y ¼ βA^þεy ð2Þ
Where Z is our instrument, A is our exposure of inter-
est, and Y is our outcome. In economic literature, Z is
referred to the exogenous variable, i.e. explained by vari-
ables outside the model, and A is the endogenous
variable, explained by other variable in the model. In the
first stage (1), the exposure is regressed on the instru-
ments. The second stage (2) regresses the outcome on
the fitted values ( A^ ) from the first stage. Given the
instrument Z meets the conditions outlined above, the
parameter estimate from fitting model (2) will provide a
consistent estimate of the causal effect of our exposure
on our outcome. Similar to the other techniques to
control for confounding in observation studies, these
assumptions are unverifiable, but reasonable when the
instrument is a genetic polymorphism. Using a genetic
variant as the instrument, also known as Mendelian
Randomization, is an appealing approach to establish
temporality and due to the lack of common causes of
the instrument and the outcome aside from population
stratification [21-23]. Although the instrumental variable
estimate will be asymptotically unbiased, in finite sam-
ples the instrumental variable estimates will be biased
towards the observed confounded association. This bias
arises because the true relationship between the instru-
ment and the exposure in the first stage of the analysis
is unknown and it must be estimated, resulting in model
over-fitting. The magnitude of this bias depends on the
strength of the association between the instrument and
the exposure [19,24]. Weak instrument bias, which is
often a concern for Mendelian Randomization studies,
can be minimized and precision increased by including
measured confounders in the two-stage analysis [25].
Using common methylenetetrahydrofolate reductase
(MTHFR) polymorphisms as our instrument, Mendelian
Randomization provides one method to assess the causal
effect of maternal folate on epigenetic profile. MTHFR
catalyzes the synthesis of 5-methylTHF, which is the
coenzyme required for homocysteine remethylation to
methionine, the precursor for the DNA methylating
agent S-adenosylmethionine. Two common polymorphism,
C677T and A1298C, are associated with reduced MTHFR
enzymatic activity, resulting in higher homocysteine levels
[26-28]. In this study we used a Mendelian Randomization
approach to assess the effect of red blood cell (RBC) folate
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mother’s MTHFR genotype was utilized as our instru-
ment, given the efficiency of maternal folate metabolism
would be expected to modify developmental exposure. A
long-term measure of folate intake, RBC folate has been
demonstrated to be responsive and sensitive to inter-
individual differences in controlled folate intake [29-31].
In a prior study of the association between of maternal
and newborn folate status, early maternal plasma folate
(~18 weeks) and self-reported folic acid supplementation
were found to be significantly associated with cord blood
folate levels [32]. In our study population of 50 newborns,
site-specific CpG methylation within the proximal pro-
moter regions of approximately 14,500 genes was analyzed
using the Illumina Infinium Human Methylation27 Bead
Chip. With the Mendelian Randomization approach we
were able to identify the causal effects of folate on epigen-
etic modifications that would have been substantially
biased given a standard regression analysis. The possible
utility of Mendelian Randomization to investigate the
causal structure of disease etiology mediated by epigenetic
modifications in observational studies has been discussed
by others [33-36], but this is the first study to apply this
approach.
Methods
The epigenetic birth cohort
Data and biospecimens were collected between June
2007 and June 2009 on the labor and delivery floor of
the Department of Obstetrics, Gynecology and Repro-
ductive Biology at Brigham and Women’s Hospital in
Boston as previously described [37]. Briefly, pregnant
women were invited to participate in our study, and
1941 completed a questionnaire, and agreed to donate
placenta and cord blood samples. Maternal and cord
blood collected from the base of the umbilical cord was
stored in EDTA tubes. Blood was processed immediately
and buffy coats were stored at −80°C. From this cohort, a
subset of 50 cord blood samples were analyzed for
genome-wide DNA methylation associated with RBC
folate. The study protocol was approved by the Institutional
Review Board of the Brigham and Women’s Hospital.
Genome-wide methylation analysis
For the current study, 1 μg of cord buffy coat DNA from
each of the 50 individuals was processed at the USC
Epigenome Center (Los Angeles, CA, USA) as previously
described [38]. For comprehensive analysis of genome-
wide methylation, the Illumina Infinium Human Methyla-
tion27 Bead Chip was used to simultaneously interrogate
methylation at 27,578 CpG sites, spanning 14,495 RefSeq
genes. On average, the Infinium array targets 2 CpG sites
per gene, with higher coverage (3–20 CpGs) for cancer-
related and imprinted genes. Data was assembled at theEpigenome Center by converting fluorescence intensities
from methylated (M) and unmethylated (U) alleles to
methylation level given by β = (M)/(M +U + 100). If signal
intensity was not significantly different from background
measurements, the β-value was recorded “NA.” The statis-
tical analysis was restricted to autosomal CpGs with
unique probe target sequences. The 50-mer oligonucleo-
tide probes were removed from further analysis if the
probe had (a) cross-reactive target(s) with at least 40
matching bases, at least 90% identity, end-nucleotide
match, and gapless sequence alignment against the target
sequence [39]. Further restriction to CpG sites with no
missing data reduced the data analysis from 23,682 to
23,264 autosomal CpGs. Methylation level for these loci
was square-root arcsine transformed to stabilize the vari-
ance. Transformed loci that were not normally distributed
at the 0.05 α-level were then removed from the dataset
(Shapiro-Wilk test). In total, 16,989 loci were analyzed in
subsequent statistical analyses.
Genotyping
Genotyping of the maternal MTHFR C677T (rs1801133)
and A1298C (rs1801131) SNPs was performed on the
ABI PRISMs 7300 Real-Time PCR System (Applied Bio-
systems, Foster City, CA, USA). Primers and probes
were ordered from TaqMan® SNP Genotyping Assays
(Applied Biosystems) MTHFR C677T (assay ID:
C___1202883) and A1298C (assay ID: C____850486).
The PCR was performed in 25 ul, with each reaction
containing 25 ng gDNA, 1.25 ul of 20× Assay Mix, 12.5 ul
of TaqMan genotyping master mix and q.s. with PCR
grade water. Cycling conditions were as follows: 50°C for
2 min, 95°C for 10 min, and 40 cycles of 92°C for 15 s and
60°C for 1 min. After the amplification, plates were
scanned by the ABI PRISMs 7500 PCR system to deter-
mine genotypes by allelic discrimination. Hardy-Weinberg
assumptions were assessed using a Chi-square test.
Red blood cell folate
Cord blood RBC folate was measured on the Roche E
Modular system (Roche Diagnostics, Indianapolis, IN) in
the laboratory of Dr. Nader Rifai at Children”s Hopital
in Boston, MA, USA. Serum and plasma folate are
sensitive to day-to-day variation in intake, reflecting
short-term diet [40,41]. We chose to assay RBC folate
given is more stable marker of long-term patterns [42].
Red blood cells were first lysed with ascorbic acid, and fol-
ate was then measured on the hemolysate. Hemoglobin
was also measured on this hemolysate to standardize RBC
folate per gram of hemoglobin. The sample was treated
with monothioglycerol and sodium hydroxide to release
the folate from endogenous binding proteins, and
incubated with a ruthenium labeled folate binding
protein, forming a folate complex. Biotinylated folate
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then added to the reaction mixture. Ruthenium labeled
biotin complexes bound to the magnetic microparticles,
and unbound reagents and sample were washed away. A
chemiluminescent reaction was electrically stimulated to
generate light, the intensity being indirectly proportional
to the amount of folate present in the sample. This assay
is approved by the Food and Drug Administration for
clinical use. The lowest detection limit of this assay is
0.6 ng/mL, and the day-to-day imprecision values at con-
centrations of 7.6, 14.3 and 19.2 ng/mL are 3.9, 3.1 and
2.0%, respectively. The normal range is 3.1 to 17.5 ng/mL.
The positively skewed RBC folate measurements were log
transformed for subsequent statistical analyses. In this co-
hort, log RBC folate ranged from 6.13 to 7.54 log (ng/mL),
with a median level of 6.664 log (ng/mL).
Statistical analysis
To estimate the effect of RBC folate on DNA methyla-
tion, we exploited Mendelian Randomization methods
using the two-stage least squares (TSLS) approach. In
the first stage, log transformed RBC folate was regressed
against MTHFR genotype modeled additively. Predicted
values from this first stage were then used to model
square-root arcsine transformed methylation levels. An
indicator for whether conception was planned, a putative
confounder, was included in both stages to increase
precision and decrease weak instrument bias. The effect
of RBC folate on methylation level using the TSLS ap-
proach was estimated for each CpG locus independently
using the AER package in R [43]. Among the sites that
had significant changes in methylation at the 0.05 α-
level, the effect of log transformed RBC folate on
untransformed β-values was estimated using TSLS.
While this yielded valid, more interpretable parameter
estimates, inference was biased due to the violation of
the ordinary least squares normality assumptions. There-
fore robust 95% confidence intervals for these estimates
were generated by bootstrapping 1000 replicates. The
UCSC Genome Browser database was used to characterize
the location of the significant CpG sites in relation to
annotated features and CpG islands [44]. Functional
enrichment among the genes in closest proximity to the
significant sites compared to all Gene Ontology (GO) an-
notated genes represented on the Illumina microarray was
evaluated based on biological process using the GOstats
package provided by Bioconductor [45]. Overrepresenta-
tion in the data set was assessed using a conditional
Hypergeometric test, which considers the relationships
between the GO terms and conditions on the significant
child terms.
The association between log transformed RBC folate
and methylation level for each CpG site, adjusting for
whether conception was planned, was also assessedusing ordinary least squares. Only conception intention
was controlled for in these standard regression models
so that the interpretation of the parameter estimates
would be comparable to the effect estimates obtained
using the TSLS method. The 10 most significant loci
identified using the ordinary least squares approach
were compared to the significant TSLS sites. Global
disparities in parameter estimates between the Mendelian
Randomization and standard approach were visualized
with a scatterplot. Pearson’s correlation was used to
formally assess the relationship between the parameter
estimates from the two methods. To assess the ability of
Mendelian Randomization to estimate the true causal
effect in the presence of unmeasured confounding com-
pared to a standard analysis, 10,000 datasets were simu-
lated with varying degrees of unmeasured confounding
and effects sizes. For each of these simulations, 50 individ-
ual exposure (xi) and outcome (yi) values were generated
as shown below:
xi ¼ α^0 þ α^1 genotypeið Þ þ α^2 conceptionið Þ þ αc uið Þ þ exi
yi ¼ β^0 þ β^1 log RBC folate½ i
 þ β^2 conceptionið Þ
þ βc uið Þ þ eyi
exi; eyi; ui ∼N 0;1ð Þ
In both the exposure and outcome models, the con-
founder ui and error term were independently normally
distributed. Parameters α^ and β^ estimated from each
significant TSLS model were assumed to be the true
population values, and were used to create the simulated
outcome and exposure values. Genotype, planned vs.
unplanned conception, and RBC folate corresponded to
the observed values of each individual. The distribution
of effect estimates were assessed among the 10,000
simulated datasets using Mendelian Randomization and
ordinary least squares approaches adjusting for concep-
tion, for αc = βc = 0.1 and 0.2. All statistical analyses were
conducted using R version 2.15.2.
Pyrosequencing
Four of CpG loci indicated to be significantly associated
with RBC folate by the MR approach were selected for
verification by pyrosequencing, chosen to reflect varying
effect sizes. These regions were in proximity to the tran-
scription start site of four genes: AIRE, GPR12, OBFC2B,
and SMG6. Pyrosequencing of the regions surrounding
these significant loci was performed by a commercial
service (EpigenDx, Worcester, MA) on a subset of 38
samples in duplicate. EpigenDx performed the bisulfite
conversion, designed the assays, and pyrosequenced the
regions, including high and low methylation controls.
The association between methylation and folate level at
each locus interrogated by pyrosequencing was estimated
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visualized by a loess curve of the site-specific estimates
plotted against genomic location.
Results and discussion
The global minor allele frequencies estimated in the
1000 Genome phase 1 population are approximately
33% for C677T (rs1801133) and 23% for the A1298C
(rs1801131). Both SNPs were in Hardy-Weinberg
equilibrium among our study population (p = 0.129;
p = 0.433). Except for a very rare cis 677 T/1298C
haplotype found in some parts of the United Kingdom
and Canada, most 677 T and 1298C alleles are associated
with 1298A and 677C alleles, respectively [46]. Thus
modeling MTHFR genotype additively corresponded to
modeling the risk associated with having zero, one, or two
common trans MTHFR variants. Modeling the number of
variants co-dominantly did not significantly explain more
variation in log transformed RBC folate than the additive
model (F = 1.335, p = 0.254).
For each variant MTHFR allele, there was significant
increase in log RBC folate, adjusting for conception
intention (F = 4.876, p = 0.0321). Elevated RBC folate
associated with MTHFR polymorphisms has been ob-
served in prior studies that also utilized radio assay
techniques [47-50]. Intent to conceive was included in
subsequent analyses as a surrogate for periconceptional
behaviors that may influence both RBC folate and
methylation level. Using maternal MTHFR genotype
modeled additively as the instrument, the TSLS approach
identified 7 CpG loci with a significant association bet-
ween log RBC folate and transformed methylation level
(Table 1). Of these significant loci, 5 were within CpG
islands, and two were associated with a CpG island shore.
A majority of these loci were within a 5′ UTR. One CpG
locus was within an enhancer, and another was promoter
associated. A one unit increase in log RBC folate was
associated with an increase in methylation level for most
of this subset. Given the levels of log RBC folate in thisTable 1 Genes in proximity to loci with a significant change in
Symbol Chr UCSC annotated features
OBFC2B 12 Promoter associated
GPR75; LOC100302652 2 5′UTR; 1st Exon; Enhancer
AIRE 21 Within 100 bp of TSS
MIMT1; PEG3;ZIM2 19 Within 500 bp of TSS; 5′UTR; 5′U
CIRBP; C19orf24 19 Body; Within 1000 bp of TSS
SMG6; SRR 17 Within 500 bp of TSS; 5′UTR
GPR12 13 5′UTR
For each significant locus, including RefSeq symbol for gene(s) in closest proximity,
estimates were reported for sites for which β^ IV from the two-stage least squares (TS
α-level, adjusting for whether conception was planned. Without this variance stabili
be correct. For interpretability, effect estimates were calculated among the significa
strapped replicates were reported.population of healthy neonates ranged from 6.13 to 7.54
log(ng/mL), a one unit change in log RBC folate was
considered to be within reasonable exposure variation.
Among the genes in closest proximity to this significant
subset of CpG loci, the regulation of dephosphorylation
and the degradation of prematurely truncated transcripts
were the most significantly enriched biological processes
(Table 2). Several enriched processes were involved in
nucleic acid transport and metabolic processing. While we
did not adjust for the possible methylation variation medi-
ated by the impact of folate on cell type distribution, only
one of the significant loci was associated with auto-
immune response, indicating cell type fluctuations were
not a major determinant of the strongest associations.
One drawback to the increased validity of the MR
approach is the decreased precision of the estimates,
precluding detection of significant results after accoun-
ting for multiple testing. While the strongest associa-
tions with folate detected using the MR approach did
not meet genome-wide significance, we contend the
decreased bias of the MR approach provides a more
compelling ranking of loci for validation. Pyrosequenc-
ing the regions surrounding four of the most significant
loci suggested these site-specific changes reflect regional
methylation variation associated with RBC folate, corro-
borating this assumption (Figure 2).
Compared to the estimates obtained using TSLS
approach, an appreciable effect of log RBC folate on
methylation level would not have been detected using
ordinary least squares (OLS), adjusting for conception
intention (Figure 3). The range of TSLS estimates was
nearly 4 times greater than that of the corresponding
ordinary least squares values, spanning from −0.371 to
0.556, compared to −0.129 to 0.144. This increased
range likely reflects both bias towards the null using the
ordinary least squares approach and the decreased preci-
sion associated with the two-stage estimation. While the
correlation between the parameter estimates was highly
significant, it was very weak due to the disparity in effectmethylation levels per one unit change in log (RBC folate)
CpG island Δ β-value Bootstrap 95% CI
Shore 0.386 (0.227, 0.551)
Island 0.349 (0.184, 0.515)
Island 0.267 (0.094, 0.444)
TR Island 0.207 (0.088, 0.332)
Island 0.176 (0.097, 0.256)
Shore 0.125 (0.039, 0.214)
Island −0.095 (−0.161, −0.030)
chromosome, UCSC annotated feature, relation to UCSC CpG island. Effect
LS) modeling the square-root arcsine beta-values were significant at the 0.05
zing transformation, the effect estimates are unbiased, but inference will not
nt sites without the transformation and 95% confidence interval for 1000 boot-
Table 2 Biological process Gene Ontology (GO) enrichment among the 7 GO annotated genes in closest proximity to
the loci significantly associated with RBC folate-level
Gene ontology term Number in
significant subset
Number in all GO
annotated genes analyzed
Odds ratio
Regulation of dephosphorylation 1 16 133.373
Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 1 19 111.111
mRNA export from nucleus 1 21 99.980
Telomere maintenance 1 24 86.913
mRNA catabolic process 1 29 71.357
Nuclear export 1 45 45.336
Humoral immune response 1 67 30.158
RNA transport 1 67 30.158
RNA localization 1 69 29.265
Nucleobase, nucleoside, nucleotide and nucleic acid transport 1 79 25.487
G-protein coupled receptor protein signaling pathway 2 534 8.915
Homeostatic process 2 555 8.558
Significant over-representation of GO terms among these 7 genes relative to the 10,024 GO annotated genes included in the original analysis was assessed using
a Hypergeometric distribution (p < 0.05).
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cant loci detected using the TSLS approach, only the
locus within the 5′ UTR of GPR12 was one of the 10
most significant sites identified using the ordinary least
squares approach (Tables 1 and 3). Besides this one site,
none of the other 10 most significant sites identified
using the ordinary least squares approach were within
the 1000 most significant sites detected using the TSLSFigure 2 Pyrosequencing the regions surrounding four of the most si
methylation variation associated with RBC folate; change in methylat
MR among the loci assayed by pyrosequencing (blue) and on the mic
the site-specific estimates plotted against genomic location.approach. Among this subset of CpG sites detected
using the ordinary least squares approach, methylation
level was only positively associated with log RBC folate
at one site (Table 3). For all other sites within this
subset, methylation level was inversely related to RBC
folate level, which was in contrast to the TSLS para-
meter estimates. These results suggested that unmea-
sured confounding generally resulted in downward bias.gnificant loci suggest site-specific changes reflect regional
ion level (%) per one unit increase log RBC folate estimated using
roarray (red). Regional changes were visualized by a loess curve of
Us
in
g 
O
LS
0.
4
0.
2
0.
0
-
0.
2
-
0.
4
0.40.20.0-0.2-0.4
Using MR
Figure 3 The observed correlation (blue line) of the
associations between methylation and log RBC folate levels, for
the 16,989 loci estimated using the Mendelian Randomization
and standard ordinary least squares methods. Methylation level
was square-root arcsine transformed to stabilize the variance. Models
adjusted for conception intention.
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methylation level estimated using TSLS to be the true
population parameters, the effect of varying degrees of
confounding on observed estimates was assessed using
both Mendelian Randomization and ordinary least
squares. For these simulations, we utilized the parame-
ters estimated by TSLS for the 7 loci significantly asso-
ciated with log RBC folate. Compared to the ordinary
least squares approach, Mendelian Randomization resul-
ted in much more accurate but less precise estimates
(Figure 4). Given a normally distributed unmeasured
confounder with a modest positive association with both
RBC folate and methylation, all observed effect estimates
were biased towards the null. However, the MendelianTable 3 Genes in proximity to the 10 loci with the most signi
per one unit increase in log(RBC folate) using the ordinary le
Symbol Chr UCSC annotated features
DMPK; DMWD 19 Within 1000 bp of TSS; 3′UTR; Enh
DAND5 19 Within 100 bp of TSS
TRIML1 4 1st Exon
GP9 3 Within 1000 bp of TSS
POLL 10 Within 1500 bp of TSS
GCNT3 15 5′UTR
FUT2 19 Within 100 bp of TSS
GPR12 13 5′UTR
FAM3D 3 Within 500 bp of TSS
COL16A1 1 5′UTR
For each significant locus, including RefSeq symbol for gene(s) in closest proximity,
Models adjusted for conception intention.Randomization estimates were substantially more robust
to this bias (Figure 4). For the ordinary least squares
models, moderate unmeasured confounding completely
removed the effect of log RBC folate on methylation
(Figure 4). While the Mendelian Randomization esti-
mates were biased in the direction of the observed
confounded relations, they were consistently closer to
the specified population parameter values than the
parameters estimated by the ordinary least squares
models. This simulation suggests that the decreased
range of estimated associations between RBC folate and
methylation level using the ordinary least squares
approach may be at least partially attributable to residual
cofounding.
Conclusions
DNA methylation has become increasing integrated into
public health studies as a modifiable indicator of the
underlying biologic changes mediating the effects of
endogenous and exogenous exposures on subsequent
disease risk. However, the field of epigenetic epidemiology
is still in its infancy and the effects of many exposures on
methylation profile have yet to be explored and verified.
In observational studies, the validity of estimated associa-
tions is always susceptible to criticism, given the possibility
of residual or unmeasured confounding. Due to an array
of factors that may influence both methylation and folate
levels, inconsistencies among previously reported asso-
ciations between maternal folate intake and neonate
methylation patterns may be the result of bias. Using an
instrumental variable approach, we were able to estimate
the causal effect of cord RBC folate on DNA methylation
level across the epigenome. While instrumental variable
analysis also requires strong unverifiable assumptions,
these assumptions are more cogent when genetic poly-
morphisms are employed as the instrument. Several
papers have outlined the potential utility of a Mendelianficant change in square-root arcsine methylation levels
ast squares approach
CpG Island Δ β-value P-value
ancer No −0.078 0.000891
No −0.047 0.001093
No −0.046 0.001603
No 0.083 0.001762
Shore −0.031 0.001852
No −0.049 0.001976
Shore −0.047 0.002012
Island −0.061 0.002106
No −0.044 0.002132
Shore −0.058 0.002294
chromosome, UCSC annotated feature, and relation to UCSC CpG island.
Modest Confounding
Moderate Confounding
−0.5
0.0
0.5
1.0
−0.5
0.0
0.5
1.0
cg08409225
cg14832904
cg17356252
cg19335327
cg13795840
cg21745320
cg22179082
CpG Locus
Es
tim
at
e
Figure 4 Sensitivity of instrumental variable effect estimate (green) and ordinary least squares estimate (blue) to modest (αc = βc = 0.1)
and moderate (αc = βc = 0.2) unmeasured confounding based on 10,000 simulations. The red bars indicate the original TSLS estimates for
the 7 significant loci modeled as the true causal effect in each simulation; the green and blue bars indicate the median instrumental variable and
ordinary least squares effect estimates in the presence of unmeasured confounding. The error bars designate the 25th and 75th percentiles of
these estimates.
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demiology [34,36]. These results demonstrate in practice,
Mendelian Randomization can be a robust method to
assess epigenetic modifications compared to the standard
ordinary least squares approach. The cost of this improved
internal validity is decreased precision. The reduction in
power associated with the two-stage estimation precluded
detection of significant changes in methylation level after
correcting for multiple testing. By accounting for both
measured and unmeasured common causes of exposure
and outcome, we assert the loci with the most significant
associations identified using the MR approach represent
the most appropriate candidates for validation. Due to the
use of a weak instrument, there is the possibility of
residual bias in the direction of the confounded relation-
ship [25]. However, simulation studies have demonstrated
that even weak instruments substantially decrease the bias
relative to the confounded association [25,51]. Our sensi-
tivity analyses similarly illustrated this robustness in the
context of epigenetic modifications. An additional draw-
back to this MR analysis is the possibility of over-fitting
the data by estimating the association between the genetic
variant and intermediate phenotype in the same cohort.
To reduce this potential bias, future studies applying MR
may consider a two-sample approach, using an external
dataset to estimate the instrument-exposure association.
However, the application of the two-sample approach
is dependent on an additional, generally unverifiableassumption that the independent cohorts are drawn from
the same underlying population. Building off the ‘Causality
Equivalence Theorem’ presented by Chen [52], another
recently suggested method to infer causal indirect effects
of genotype on outcome relies on a series of models to
statistically test necessary conditional independencies
between covariates [53]. However, the application of this
approach was deemed inappropriate given the associations
between RBC folate and methylation level conditional on
MTHFR genotype were likely influenced by common
unmeasured causes of folate and methylation levels.
Although the Mendelian Randomization method pro-
vides valid estimates of the causal effect of RBC folate
on methylation level across the genome, there is some
uncertainty as to the functional implications. A majority
of the significant loci were within the 5′ UTR of RefSeq
annotated genes, while a few were located within the
gene body or associated with a regulatory element, for
which methylation may have disparate effects on tran-
scriptional regulation. However, future studies can utilize
these results to guide investigation of potential pathways
mediating the influence of folate levels on developmental
outcomes. These results should also be considered in
the context of the samples analyzed, considering even
closely related cell types, such as haematopoietic line-
ages, exhibit discrepancies in the methylome [54]. While
this MR approach is robust to underlying disparities in
cell type distribution that may influence both folate and
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http://www.biomedcentral.com/1471-2105/14/353methylation levels, it does not adjust for any down-
stream effects of RBC folate on cell type distribution that
may impact observed changes in methylation. As a
mediator, the analysis of the association between RBC
folate and methylation is still valid without adjustment
for cell type distribution. In this context, both fluctua-
tions in cell type distribution and cell type-specific
methylation may be meaningful, but these forms of
variation are not partitioned by this analysis. Given this
change in cell type distribution may be a component of
the total effect RBC folate on methylation level and the
inability to disambiguate the temporality of RBC folate
and cell type distribution, we did not adjust for cell type
distribution through recently proposed regression cali-
bration techniques [54]. However, future studies of DNA
methylation should be cognizant the potential impact of
cell distribution when defining biologically meaningful
variation given the specific research question.
Using a novel application of Mendelian Randomization
methods to DNA methylation data, this study was able
to provide insight into the biological mechanism media-
ting the effects of maternal folate on fetal development.
An array of socioeconomic and culture factors influence
individual diet and other environmental exposures that
may also alter the epigenome. Given the many putative
determinants of DNA methylation levels, there is a high
likelihood of unmeasured confounding using standard
regression techniques to assess the association between
RBC folate and methylation levels. This study demon-
strated that the amalgamation of these unmeasured
predictors of folate and methylation level generally
biases effect estimates towards the null. Using Mendel-
ian Randomization methods it was possible to identify a
significant, appreciable effect of RBC folate on methyla-
tion level of several CpG loci in cord blood that would
have otherwise been obfuscated using standard regression
techniques. Future studies will be able to use these results
to guide additional analysis of the effects of periconcep-
tional folate on candidate pathways. More generally, this
study demonstrated the utility of Mendelian Randomization
for the assessment of epigenetic modifications.
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